Bank Of America Corp Aptevo Therapeutics Inc. Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$1.74 - $2.54 $8 - $12	-5 Reduced 45.45%	6 $0
Q4 2022 Feb 10, 2023	SELL	$2.0 - $138.16 $3,886 - $268,444	-1,943 Reduced 99.44%	11 $0
Q3 2022 Nov 14, 2022	BUY	$3.12 - $142.56 $6,077 - $277,706	1,948 Added 32466.67%	1,954 $6,000
Q4 2021 Feb 08, 2022	SELL	$6.48 - $17.49 $149 - $402	-23 Reduced 79.31%	6 $0
Q3 2021 Nov 15, 2021	BUY	$15.01 - $22.16 $300 - $443	20 Added 222.22%	29 $0
Q2 2021 Sep 13, 2021	BUY	$21.85 - $30.0 $196 - $270	9 New	9 $0

Ticker APVO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,090,640
Market Cap $22.4M
Description
Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelo...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.